Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Signaling pathways

Items 411-420 of 7862

Page
per page
  1. FB23-2
    BA2728 FB23-2
    Summary: FB23-2 is a potent and selective inhibitor of mRNAN-methyladenine demethylase.
      ≥53.9 mg/mL
  2. Brusatol
    BA2729 Brusatol
    Summary: Brusatol (NSC172924) is a unique pathway inhibitor that sensitizes a wide range of cancer cells to Cisplatin and other chemotherapeutically active molecules.
  3. GSK2795039
    BA2730 GSK2795039
    Summary: GSK2795039 is a NADPH oxidase 2 inhibitor that averaged 6 in different cell-free assays.
  4. Iberdomide
    BA2731 Iberdomide
    Summary: Iberdomide (CC-220) is an orally effective (CRBN) E3 ligase modulator.
      ≥24.15 mg/mL
  5. Isoginkgetin
    BA2732 Isoginkgetin
    Summary: Isoginkgetin is an inhibitor.
  6. WM-3835
    BA2733 WM-3835
    Summary: WM-3835 is a potent, highly specific(or) inhibitor.
  7. Raptinal
    BA2734 Raptinal
    Summary: Direct activation of Raptinal initiates apoptosis-dependent endogenous pathways.
  8. HA15
    BA2735 HA15
    Summary: HA15 is a potent and specific inhibitor of endoplasmic reticulum chaperonin.
  9. Takinib
    BA2736 Takinib
    Summary: Takinib (EDHS-206) is a potent and selective inhibitor (=9.5nM)
  10. Metoprolol
    BA2737 Metoprolol
    Summary: Metoprolol is an orally active, selective beta1-adrenoceptor antagonist.

Items 411-420 of 7862

Page
per page